ST
GILD icon

Smithfield Trust’s Gilead Sciences GILD Stock Holding History

Smithfield Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
1,402
+142
+11% +$19.9K 0.01% 374
2025
Q4 		$155K Hold
1,260
– – 0.01% 400
2025
Q3 		$140K Sell
1,260
-250
-17% -$28.4K 0.01% 406
2025
Q2 		$168K Hold
1,510
– – 0.01% 365
2025
Q1 		$169K Hold
1,510
– – 0.01% 369
2024
Q4 		$140K Hold
1,510
– – 0.01% 397
2024
Q3 		$127K Buy
1,510
+440
+41% +$33.6K 0.01% 416
2024
Q2 		$73K Sell
1,070
-400
-27% -$26.7K ﹤0.01% 487
2024
Q1 		$107K Hold
1,470
– – 0.01% 438
2023
Q4 		$119K Hold
1,470
– – 0.01% 402
2023
Q3 		$108K Sell
1,470
-403
-22% -$31K 0.01% 401
2023
Q2 		$145K Hold
1,873
– – 0.01% 357
2023
Q1 		$156K Hold
1,873
– – 0.01% 343
2022
Q4 		$161K Hold
1,873
– – 0.01% 328
2022
Q3 		$115K Hold
1,873
– – 0.01% 366
2022
Q2 		$115K Buy
1,873
+268
+17% +$16.6K 0.01% 389
2022
Q1 		$96K Buy
1,605
+135
+9% +$8.63K 0.01% 446
2021
Q4 		$107K Sell
1,470
-400
-21% -$27.6K 0.01% 436
2021
Q3 		$131K Hold
1,870
– – 0.01% 385
2021
Q2 		$129K Sell
1,870
-30
-2% -$2K 0.01% 390
2021
Q1 		$123K Sell
1,900
-392
-17% -$25.3K 0.01% 399
2020
Q4 		$134K Buy
2,292
+360
+19% +$21.7K 0.01% 380
2020
Q3 		$122K Sell
1,932
-257
-12% -$17.8K 0.01% 368
2020
Q2 		$168K Buy
2,189
+1,200
+121% +$92K 0.02% 298
2020
Q1 		$74K Sell
989
-20
-2% -$1.38K 0.01% 383
2019
Q4 		$66K Sell
1,009
-1,726
-63% -$112K 0.01% 468
2019
Q3 		$173K Buy
2,735
+437
+19% +$28.6K 0.02% 289
2019
Q2 		$155K Buy
2,298
+250
+12% +$16.4K 0.02% 313
2019
Q1 		$133K Sell
2,048
-600
-23% -$39.9K 0.01% 325
2018
Q4 		$165K Sell
2,648
-820
-24% -$57.3K 0.02% 261
2018
Q3 		$267K Sell
3,468
-672
-16% -$50.8K 0.03% 230
2018
Q2 		$293K Sell
4,140
-190
-4% -$13.4K 0.03% 211
2018
Q1 		$326K Sell
4,330
-542
-11% -$43.1K 0.04% 199
2017
Q4 		$349K Sell
4,872
-18
-0.4% -$1.37K 0.04% 197
2017
Q3 		$397K Hold
4,890
– – 0.05% 184
2017
Q2 		$346K Hold
4,890
– – 0.05% 195
2017
Q1 		$332K Sell
4,890
-1,730
-26% -$122K 0.05% 195
2016
Q4 		$474K Sell
6,620
-217
-3% -$16.1K 0.08% 159
2016
Q3 		$541K Buy
6,837
+3,284
+92% +$267K 0.1% 124
2016
Q2 		$296K Sell
3,553
-1,756
-33% -$156K 0.06% 198
2016
Q1 		$487K Sell
5,309
-912
-15% -$82.2K 0.09% 136
2015
Q4 		$630K Sell
6,221
-677
-10% -$70.4K 0.13% 109
2015
Q3 		$677K Buy
6,898
+1,244
+22% +$138K 0.14% 103
2015
Q2 		$662K Buy
5,654
+1,936
+52% +$212K 0.13% 113
2015
Q1 		$365K Buy
3,718
+400
+12% +$40.6K 0.07% 203
2014
Q4 		$313K Buy
3,318
+99
+3% +$10.2K 0.06% 224
2014
Q3 		$342K Buy
3,219
+2,989
+1,300% +$293K 0.07% 217
2014
Q2 		$19K Hold
230
– – ﹤0.01% 654
2014
Q1 		$17K Buy
230
+110
+92% +$8.63K ﹤0.01% 651
2013
Q4 		$9K Buy
+120
New +$8.36K ﹤0.01% 703

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Smithfield Trust's GILD Position: Q1 2026 in Review

Smithfield Trust increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $19.9K and bringing the position to 1,402 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #374.

Smithfield Trust first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $677K in Q3 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Smithfield Trust held 1,402 shares of Gilead Sciences worth $196K as of Q1 2026.
  • Smithfield Trust bought 142 Gilead Sciences shares in Q1 2026, an estimated $19.9K.
  • Gilead Sciences made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #374 holding.
  • Smithfield Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Smithfield Trust's Gilead Sciences position peaked at $677K in Q3 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.